[1]
|
Visan, I. (2020) Inflammasomes Drive Tau Pathology. Nature Immunology, 21, Article No. 8.
https://doi.org/10.1038/s41590-019-0572-1
|
[2]
|
Alessandri, A.L., Sousa, L.P., Lucas, C.D., et al. (2013) Resolu-tion of Inflammation: Mechanisms and Opportunity for Drug Development. Pharmacology & Therapeutics, 139, 189-212.
https://doi.org/10.1016/j.pharmthera.2013.04.006
|
[3]
|
Iqbal, A.J., Fisher, E.A. and Greaves, D.R. (2016) Inflam-mation—A Critical Appreciation of the Role of Myeloid Cells. Microbiology Spectrum, 4. https://doi.org/10.1128/microbiolspec.MCHD-0027-2016
|
[4]
|
Friedenstein, A.J., Gorskaja, J.F. and Kulagina, N.N. (1976) Fibroblast Precursors in Normal and Irradiated Mouse Hematopoietic Organs. Experimental Hematology, 4, 267-274.
|
[5]
|
Dominici, M., Le Blanc, K., Mueller, I., et al. (2006) Minimal Criteria for Defining Multipotent Mesen-chymal Stromal Cells. The International Society for Cellular Therapy Position Statement. Cytotherapy, 8, 315-317.
https://doi.org/10.1080/14653240600855905
|
[6]
|
Polisetti, N., Chaitanya, V.G., Babu, P.P. and Vemuganti, G.K. (2010) Isolation, Characterization and Differentiation Potential of Rat Bone Marrow Stromal Cells. Neurology India, 58, 201-208. https://doi.org/10.4103/0028-3886.63789
|
[7]
|
段长伟, 柴彦杰, 赵疆东, 等. 骨髓间充质干细胞分离与培养技术[J]. 宁夏医学杂志, 2021, 43(6): 573-576.
https://doi.org/10.13621/j.1001-5949.2021.06.0573
|
[8]
|
Insausti, C.L., Blanquer, M.B., Olmo, L.M., et al. (2012) Isolation and Characterization of Mesenchymal Stem Cells from the Fat Layer on the Density Gradient Separated Bone Marrow. Stem Cells and Development, 21, 260-272.
https://doi.org/10.1089/scd.2010.0572
|
[9]
|
Zohar, R., Sodek, J. and McCulloch, C.A. (1997) Characterization of Stromal Progenitor Cells Enriched by Flow Cytometry. Blood, 90, 3471-3481. https://doi.org/10.1182/blood.V90.9.3471
|
[10]
|
Encina, N.R., Billotte, W.G. and Hofmann, M.C. (1999) Immuno-magnetic Isolation of Osteoprogenitors from Human Bone Marrow Stroma. Laboratory Investigation: A Journal of Technical Methods and Pathology, 79, 449-457.
|
[11]
|
刘元果 & 刘志勇. (2015).大鼠骨髓间充质干细胞分离、培养与鉴定.现代医学(03),291-296.
|
[12]
|
Zhou, Y., Yamamoto, Y., Xiao, Z. and Ochiya, T. (2019) The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity. Journal of Clinical Medicine, 8, Article No. 1025.
https://doi.org/10.3390/jcm8071025
|
[13]
|
Song, W.J., Li, Q., Ryu, M.-O., et al. (2018) TSG-6 Released from In-traperitoneally Injected Canine Adipose Tissue-Derived Mesenchymal Stem Cells Ameliorate Inflammatory Bowel Dis-ease by Inducing M2 Macrophage Switch in Mice. Stem Cell Research & Therapy, 9, Article No. 91. https://doi.org/10.1186/s13287-018-0841-1
|
[14]
|
Geng, Y., Zhang, L., Fu, B., et al. (2014) Mesenchymal Stem Cells Ameliorate Rhabdomyolysis-Induced Acute Kidney Injury via the Activation of M2 Macrophages. Stem Cell Re-search & Therapy, 5, Article No. 80.
https://doi.org/10.1186/scrt469
|
[15]
|
Zhou, G., Yu, L., Fang, L., et al. (2018) CD177+ Neutrophils as Functionally Activated Neutrophils Negatively Regulate IBD. Gut, 67, 1052-1063. https://doi.org/10.1136/gutjnl-2016-313535
|
[16]
|
Ye, Q., Wang, B. and Mao, J. (2020) The Pathogenesis and Treatment of the ‘Cytokine Storm’ in COVID-19. The Journal of Infection, 80, 607-613. https://doi.org/10.1016/j.jinf.2020.03.037
|
[17]
|
Zindl, C.L., Lai, J.-F., Lee, Y.K., et al. (2013) IL-22-Producing Neutrophils Contribute to Antimicrobial Defense and Restitution of Colonic Epithelial Integrity during Colitis. Proceed-ings of the National Academy of Sciences of the United States of America, 110, 12768-12773. https://doi.org/10.1073/pnas.1300318110
|
[18]
|
Bacskai, I., Mázló, A., Kis-Tóth, K., et al. (2015) Mesenchymal Stromal Cell-Like Cells Set the Balance of Stimulatory and Inhibitory Signals in Monocyte-Derived Dendritic Cells. Stem Cells and Development, 24, 1805-1816.
https://doi.org/10.1089/scd.2014.0509
|
[19]
|
English, K., Barry, F.P. and Mahon, B.P. (2008) Murine Mesenchymal Stem Cells Suppress Dendritic Cell Migration, Maturation and Antigen Presentation. Immunology Letters, 115, 50-58. https://doi.org/10.1016/j.imlet.2007.10.002
|
[20]
|
Djouad, F., Charbonnier, L.-M., et al. (2007) Mesenchymal Stem Cells Inhibit the Differentiation of Dendritic Cells through an Interleukin-6-Dependent Mechanism. Stem Cells, 25, 2025-2032.
https://doi.org/10.1634/stemcells.2006-0548
|
[21]
|
Liu, Y., Yin, Z., Zhang, R., et al. (2014) MSCs Inhibit Bone Marrow-Derived DC Maturation and Function through the Release of TSG-6. Biochemical and Biophysical Research Communications, 450, 1409-1415.
https://doi.org/10.1016/j.bbrc.2014.07.001
|
[22]
|
Benkhoucha, M., Molnarfi, N., et al. (2014) Hepatocyte Growth Factor Limits Autoimmune Neuroinflammation via Glucocorticoid-Induced Leucine Zipper Expression in Dendritic Cells. Journal of Immunology, 193, 2743-2752.
https://doi.org/10.4049/jimmunol.1302338
|
[23]
|
Spaggiari, G.M., Capobianco, A., Becchetti, S., Mingari, M.C. and Moretta, L. (2006) Mesenchymal Stem Cell-Natural Killer Cell Interactions: Evidence That Activated NK Cells Are Ca-pable of Killing MSCs, Whereas MSCs Can Inhibit IL-2-Induced NK-Cell Proliferation. Blood, 107, 1484-1490. https://doi.org/10.1182/blood-2005-07-2775
|
[24]
|
Sotiropoulou, P.A., Perez, S.A., Gritzapis, A.D., Baxevanis, C.N. and Papamichail, M. (2006) Interactions between Human Mesenchymal Stem Cells and Natural Killer Cells. Stem Cells, 24, 74-85.
https://doi.org/10.1634/stemcells.2004-0359
|
[25]
|
Spaggiari, G.M., Capobianco, A., et al. (2008) Mesenchymal Stem Cells Inhibit Natural Killer-Cell Proliferation, Cytotoxicity, and Cytokine Production: Role of Indoleamine 2,3-Dioxygenase and Prostaglandin E2. Blood, 111, 1327-1333. https://doi.org/10.1182/blood-2007-02-074997
|
[26]
|
Selmani, Z., Naji, A., Zidi, I., et al. (2008) Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells. Stem Cells, 26, 212-222. https://doi.org/10.1634/stemcells.2007-0554
|
[27]
|
Krampera, M., Glennie, S., Dyson, J., et al. (2003) Bone Marrow Mesenchymal Stem Cells Inhibit the Response of Naive and Memory Antigen-Specific T Cells to Their Cognate Peptide. Blood, 101, 3722-3729.
https://doi.org/10.1182/blood-2002-07-2104
|
[28]
|
Ren, G., Zhao, X., Zhang, L., et al. (2010) Inflammatory Cyto-kine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression. Journal of Immunology, 184, 2321-2328. https://doi.org/10.4049/jimmunol.0902023
|
[29]
|
Del Papa, B., Sportoletti, P., Cecchini, D., et al. (2013) Notch1 Modulates Mesenchymal Stem Cells Mediated Regulatory T-Cell Induction. European Journal of Immunology, 43, 182-187. https://doi.org/10.1002/eji.201242643
|
[30]
|
Wang, G., Zhang, S., et al. (2013) Expression and Biological Function of Programmed Death Ligands in Human Placenta Mesenchymal Stem Cells. Cell Biology International, 37, 137-148. https://doi.org/10.1002/cbin.10024
|
[31]
|
Liotta, F., Angeli, R., Cosmi, L., et al. (2008) Toll-Like Recep-tors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling. Stem Cells, 26, 279-289. https://doi.org/10.1634/stemcells.2007-0454
|
[32]
|
Ren, G., Zhang, L., Zhao, X., et al. (2008) Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide. Cell Stem Cell, 2, 141-150. https://doi.org/10.1016/j.stem.2007.11.014
|
[33]
|
Franquesa, M., Mensah, F.K., Huizinga, R., et al. (2015) Human Adipose Tissue-Derived Mesenchymal Stem Cells Abrogate Plasmablast Formation and Induce Regulatory B Cells Independently of T Helper Cells. Stem Cells, 33, 880-891. https://doi.org/10.1002/stem.1881
|
[34]
|
Healy, M.E., Bergin, R., Mahon, B.P. and English, K. (2015) Mesenchymal Stromal Cells Protect against Caspase 3-Mediated Apoptosis of CD19+ Peripheral B Cells through Contact-Dependent Upregulation of VEGF. Stem Cells and Develop-ment, 24, 2391-2402. https://doi.org/10.1089/scd.2015.0089
|
[35]
|
Barrio, L., Cuevas, V.D., Menta, R., et al. (2014) Human Adipose Tissue-Derived Mesenchymal Stromal Cells Promote B-Cell Motility and Chemoattraction. Cytotherapy, 16, 1692-1699. https://doi.org/10.1016/j.jcyt.2014.07.012
|
[36]
|
Corcione, A., Benvenuto, F., Ferretti, E., et al. (2006) Human Mesenchymal Stem Cells Modulate B-Cell Functions. Blood, 107, 367-372. https://doi.org/10.1182/blood-2005-07-2657
|
[37]
|
Tabera, S., Pérez-Simón, J.A., Díez-Campelo, M., et al. (2008) The Effect of Mesenchymal Stem Cells on the Viability, Proliferation and Differentiation of B-Lymphocytes. Haemato-logica, 93, 1301-1309.
https://doi.org/10.3324/haematol.12857
|
[38]
|
Karp, J.M. and Leng Teo, G.S. (2009) Mesenchymal Stem Cell Hom-ing: The Devil Is in the Details. Cell Stem Cell, 4, 206-216. https://doi.org/10.1016/j.stem.2009.02.001
|
[39]
|
Nitzsche, F., Müller, C., Lukomska, B., et al. (2017) Concise Re-view: MSC Adhesion Cascade-Insights into Homing and Transendothelial Migration. Stem Cells, 35, 1446-1460. https://doi.org/10.1002/stem.2614
|
[40]
|
Ullah, M., Liu, D.D. and Thakor, A.S. (2019) Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement. iScience, 15, 421-438. https://doi.org/10.1016/j.isci.2019.05.004
|
[41]
|
Han, Y., Li, X., Zhang, Y., et al. (2019) Mesenchymal Stem Cells for Regenerative Medicine. Cells, 8, Article No. 886.
https://doi.org/10.3390/cells8080886
|
[42]
|
Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., et al. (2002) Pluripotency of Mesenchymal Stem Cells Derived from Adult Marrow. Nature, 418, 41-49. https://doi.org/10.1038/nature00870
|
[43]
|
Barker N. (2014) Adult Intestinal Stem Cells: Critical Drivers of Epithelial Homeostasis and Regeneration. Nature Reviews Molecular Cell Biology, 15, 19-33. https://doi.org/10.1038/nrm3721
|
[44]
|
Wang, C., Li, Y., Yang, M., et al. (2018) Efficient Differentiation of Bone Marrow Mesenchymal Stem Cells into Endothelial Cells in Vitro. European Journal of Vascular and Endovascular Sur-gery, 55, 257-265.
https://doi.org/10.1016/j.ejvs.2017.10.012
|
[45]
|
De Almeida, D.C., Donizetti-Oliveira, C., Barbosa-Costa, P., et al. (2013) In Search of Mechanisms Associated with Mesenchymal Stem Cell-Based Therapies for Acute Kidney Injury. The Clinical Biochemist Reviews, 34, 131-144.
|
[46]
|
Li, N. and Hua, J. (2017) Interactions between Mesenchymal Stem Cells and the Immune System. Cellular and Molecular Life Sciences, 74, 2345-2360. https://doi.org/10.1007/s00018-017-2473-5
|
[47]
|
Caplan, A.I. and Dennis, J.E. (2006) Mesenchymal Stem Cells as Trophic Mediators. Journal of Cellular Biochemistry, 98, 1076-1084. https://doi.org/10.1002/jcb.20886
|
[48]
|
Baglio, S.R., Rooijers, K., Koppers-Lalic, D., et al. (2015) Human Bone Marrow- and Adipose-Mesenchymal Stem Cells Secrete Exosomes Enriched in Distinctive miRNA and tRNA Species. Stem Cell Research & Therapy, 6, Article No. 127. https://doi.org/10.1186/s13287-015-0116-z
|
[49]
|
Panés, J., García-Olmo, D., Van Assche, G., et al. (2016) Ex-panded Allogeneic Adipose-Derived Mesenchymal Stem Cells (Cx601) for Complex Perianal Fistulas in Crohn’s Dis-ease: A Phase 3 Randomised, Double-Blind Controlled Trial. Lancet, 388, 1281-1290. https://doi.org/10.1016/S0140-6736(16)31203-X
|
[50]
|
Izadi, M., Nejad, A.S.H., et al. (2022) Mesenchymal Stem Cell Transplantation in Newly Diagnosed Type-1 Diabetes Patients: A Phase I/II Randomized Placebo-Controlled Clini-cal Trial. Stem Cell Research & Therapy, 13, Article No. 264. https://doi.org/10.1186/s13287-022-02941-w
|
[51]
|
Kang, S.J., Gu, N.-Y., Byeon, J.S., et al. (2023) Immunomodu-latory Effects of Canine Mesenchymal Stem Cells in an Experimental Atopic Dermatitis Model. Frontiers in Veterinary Science, 10, Article 1201382.
https://doi.org/10.3389/fvets.2023.1201382
|
[52]
|
Liang, J., Zhang, H., Hua, B., et al. (2010) Allogenic Mesenchy-mal Stem Cells Transplantation in Refractory Systemic Lupus Erythematosus: A Pilot Clinical Study. Annals of the Rheumatic Diseases, 69, 1423-1429.
https://doi.org/10.1136/ard.2009.123463
|
[53]
|
Ruane, J.J., Ross, A., Zigmont, V., et al. (2021) A Single-Blinded Randomized Controlled Trial of Mesenchymal Stem Cell Therapy for the Treatment of Osteoarthritis of the Knee with Active Control. Journal of Stem Cells & Regenerative Medicine, 17, 3-17. https://doi.org/10.46582/jsrm.1701002
|
[54]
|
Vij, R., Stebbings, K.A., Kim, H., Park, H. and Chang, D. (2022) Safety and Efficacy of Autologous, Adipose-Derived Mesenchymal Stem Cells in Patients with Rheumatoid Arthritis: A Phase I/IIa, Open-Label, Non-Randomized Pilot Trial. Stem Cell Research & Therapy, 13, Article No. 88. https://doi.org/10.1186/s13287-022-02763-w
|
[55]
|
Nabavi, S.M., Karimi, S., Arab, L., et al. (2023) Intravenous Transplantation of Bone Marrow-Derived Mesenchymal Stromal Cells in Patients with Multiple Sclerosis, a Phase I/IIa, Double Blind, Randomized Controlled Study. Multiple Sclerosis and Related Disorders, 78, Article ID: 104895.
https://doi.org/10.1016/j.msard.2023.104895
|
[56]
|
Schiess, M., Suescun, J., Doursout, M.F., et al. (2021) Alloge-neic Bone Marrow-Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson’s Disease. Movement Disorders, 36, 1825-1834. https://doi.org/10.1002/mds.28582
|